Modular Medical, Inc. (MODD)
NASDAQ: MODD · Real-Time Price · USD
0.8510
-0.0263 (-3.00%)
Jun 4, 2025, 1:32 PM - Market open
Company Description
Modular Medical, Inc. operates as a medical device company.
It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes.
The company is headquartered in San Diego, California.
Modular Medical, Inc.
| Country | United States |
| Founded | 1998 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 40 |
| CEO | James Besser |
Contact Details
Address: 10740 Thornmint Road San Diego, California 92127 United States | |
| Phone | (858) 800-3500 |
| Website | modularmedical.com |
Stock Details
| Ticker Symbol | MODD |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001074871 |
| CUSIP Number | 60785L207 |
| ISIN Number | US60785L2079 |
| Employer ID | 87-0620495 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| James E. Besser | Chief Executive Officer |
| Paul M. DiPerna | Founder, Chairman, President, Chief Financial Officer and Treasurer |
| Kevin Schmid | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 28, 2025 | 8-K | Current Report |
| May 22, 2025 | EFFECT | Notice of Effectiveness |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| May 15, 2025 | SCHEDULE 13G/A | Filing |
| May 13, 2025 | 424B3 | Prospectus |
| May 7, 2025 | EFFECT | Notice of Effectiveness |
| May 6, 2025 | S-3/A | [Amend] Registration statement under Securities Act of 1933 |
| Apr 25, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 7, 2025 | SCHEDULE 13D/A | Filing |